Opinion

Video

Selecting Optimal Treatment in BCG-Unresponsive NMIBC

Author(s):

Gordon A. Brown, DO,Siamak Daneshmand, MD

A panel of experts provide clinical insights on factors that inform how they select treatments for patients with BCG-unresponsive non–muscle invasive bladder cancer.

Related Videos
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Joshua J. Meeks, MD, PhD, gives an answer during a Zoom video interview
Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
Related Content
Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
May 12th 2025

Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC

Hannah Clarke
The phase 3 RC48-C016 trial met its primary end points.
medical depiction of bladder cancer
May 31st 2023

Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

Urology Times staff
In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
May 7th 2025

Physical function and frailty measures offer distinct insights in patients with bladder cancer

Hannah Clarke
Data showed that physical function and self-reported frailty assessments were poorly correlated.
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
May 26th 2022

Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease

Urology Times staff
“We know that erectile dysfunction is really an important issue that can be a harbinger for other underlying cardiovascular or neurological health issues,” says Michael Lutz, MD.
FDA issues refusal to file letter on sBLA for nogapendekin alfa inbakicept
May 5th 2025

FDA issues refusal to file letter on sBLA for nogapendekin alfa inbakicept

Hannah Clarke
The sBLA for NAI was submitted to the FDA in March 2025.
FDA updates in urology: April 2025
May 1st 2025

FDA updates in urology: April 2025

Hannah Clarke
A recap of the FDA submissions and regulatory decisions in urology from April 2025.
© 2025 MJH Life Sciences

All rights reserved.